APA (7th ed.) Citation

Dong, H., Li, S., Peng, Y., Zhang, X., Zheng, J., Xue, C., . . . Cui, H. (2025). Durvalumab‑induced type 1 diabetes mellitus in lung adenocarcinoma: A case report and literature review. Oncology Letters, 29(6), N.PAG. https://doi.org/10.3892/ol.2025.15023

Chicago Style (17th ed.) Citation

Dong, Huijing, et al. "Durvalumab‑induced Type 1 Diabetes Mellitus in Lung Adenocarcinoma: A Case Report and Literature Review." Oncology Letters 29, no. 6 (2025): N.PAG. https://doi.org/10.3892/ol.2025.15023.

MLA (9th ed.) Citation

Dong, Huijing, et al. "Durvalumab‑induced Type 1 Diabetes Mellitus in Lung Adenocarcinoma: A Case Report and Literature Review." Oncology Letters, vol. 29, no. 6, 2025, p. N.PAG, https://doi.org/10.3892/ol.2025.15023.